Kyntra Bio, Inc. (KYNB)
6.97
-0.05
(-0.71%)
USD |
NASDAQ |
Mar 13, 16:00
7.01
+0.04
(+0.57%)
After-Hours: 20:00
Kyntra Bio Total Assets (Quarterly) : 137.01M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gossamer Bio, Inc. | 208.82M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 119.53M |
| Shareholders Equity (Quarterly) | -17.03M |
| Debt to Equity Ratio | -1.236 |
| Current Ratio | 3.709 |
| Net Debt Paydown Yield | 57.66% |